Prevalence of chronic kidney disease and survival among aboriginal people

被引:84
作者
Gao, Song
Manns, Braden J.
Culleton, Bruce F.
Tonelli, Marcello
Quan, Hude
Crowshoe, Lynden
Ghali, William A.
Svenson, Lawrence W.
Hemmelgarn, Brenda R.
机构
[1] Univ Calgary, Div Nephrol, Dept Med, Foothills Hosp, Calgary, AB T2N 2T9, Canada
[2] Univ Calgary, Div Gen Internal Med, Calgary, AB, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB, Canada
[5] Univ Calgary, Dept Family Med, Calgary, AB, Canada
[6] Univ Alberta, Div Nephrol, Dept Med, Edmonton, AB, Canada
[7] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada
[8] Univ Alberta, Inst Hlth Econ, Edmonton, AB, Canada
[9] Univ Alberta, Alberta Hlth & Wellness, Edmonton, AB, Canada
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 11期
关键词
D O I
10.1681/ASN.2007030360
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Globally, it is known that the incidence of end-stage renal disease is higher among Aboriginals, but it is unknown whether this is due to an increased prevalence of chronic kidney disease or other unidentified factors. We studied 658,664 people of non-First Nations and 14,989 people of First Nations and found that the age- and sex-adjusted prevalence of chronic kidney disease was significantly higher among those of non-First Nations compared to those of First Nations (67.5 versus 59.5 per 1000 population; P <0.0001). However, severe chronic kidney disease (estimated glomerular filtration rate <30 ml/min per 1.73 m(2)) was almost two-fold higher among people of First Nations (P < 0.0001). Cox proportional hazards models suggested that compared to people of non-First Nations, those of First Nations with chronic kidney disease had a 77% increased risk of death after adjusting for age, gender, diabetes and baseline eGFR. In conclusion, whether the higher incidence of end-stage renal disease among people of First Nations is due to suboptimal management of chronic kidney disease and its associated comorbidities, more rapid loss of kidney function, or other unidentified factors remains to be determined.
引用
收藏
页码:2953 / 2959
页数:7
相关论文
共 43 条
[1]  
[Anonymous], STAT PROF HLTH 1 NAT
[2]  
[Anonymous], USRDS 1998 ANN DAT R
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]   Prevalence of diabetes among native Americans and Alaska natives, 1990-1997 - An increasing burden [J].
Burrows, NR ;
Geiss, LS ;
Engelgau, MM ;
Acton, KJ .
DIABETES CARE, 2000, 23 (12) :1786-1790
[5]   Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000 [J].
Coresh, J ;
Byrd-Holt, D ;
Astor, BC ;
Briggs, JP ;
Eggers, PW ;
Lacher, DA ;
Hostetter, TH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01) :180-188
[6]  
Dyck RF, 1998, CLIN INVEST MED, V21, P33
[7]   Mechanisms of renal disease in indigenous populations: influences at work in Canadian indigenous peoples [J].
Dyck, RF .
NEPHROLOGY, 2001, 6 (01) :3-7
[8]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[9]   END-STAGE RENAL-DISEASE IN US MINORITY-GROUPS [J].
FELDMAN, HI ;
KLAG, MJ ;
CHIAPELLA, AP ;
WHELTON, PK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (05) :397-410
[10]   Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance [J].
Garg, AX ;
Mamdani, M ;
Juurlink, DN ;
van Walraven, C .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1433-1439